ICD-10: A52.79

Other symptomatic late syphilis

Clinical Information

Inclusion Terms

  • Syphilitic splenomegaly
  • Syphilis of thyroid gland
  • Late syphilitic leukoderma
  • Syphilis of pituitary gland
  • Syphilis of adrenal gland

Additional Information

Clinical Information

The ICD-10 code A52.79 refers to "Other symptomatic late syphilis," which encompasses a range of clinical presentations, signs, symptoms, and patient characteristics associated with the late stages of syphilis infection. Understanding these aspects is crucial for accurate diagnosis and effective management of the disease.

Clinical Presentation of Late Syphilis

Late syphilis, also known as tertiary syphilis, typically occurs years after the initial infection if left untreated. It can manifest in various forms, affecting multiple organ systems. The clinical presentation may include:

  • Gummatous Syphilis: Characterized by the formation of gummas, which are soft, tumor-like growths that can occur in various tissues, including skin, bones, and internal organs.
  • Cardiovascular Syphilis: This form can lead to aortitis, which is inflammation of the aorta, potentially resulting in aneurysms or other cardiovascular complications.
  • Neurosyphilis: Involves the central nervous system and can present with a range of neurological symptoms, including headaches, altered mental status, and seizures.

Signs and Symptoms

The signs and symptoms of other symptomatic late syphilis can vary widely depending on the specific complications that arise. Common manifestations include:

  • Skin Lesions: Gummas may appear as raised, painless lesions on the skin or mucous membranes.
  • Bone Pain: Patients may experience pain in the bones due to gummatous lesions affecting the skeletal system.
  • Cardiovascular Symptoms: These may include chest pain, shortness of breath, or signs of heart failure due to cardiovascular involvement.
  • Neurological Symptoms: Patients may present with cognitive decline, personality changes, or other neurological deficits if the central nervous system is affected.

Patient Characteristics

Certain patient characteristics may influence the presentation and progression of late syphilis:

  • Demographics: Late syphilis is more prevalent in certain populations, including men who have sex with men (MSM) and individuals with a history of high-risk sexual behavior.
  • Co-morbidities: Patients with compromised immune systems, such as those living with HIV, may experience more severe manifestations of syphilis.
  • History of Treatment: Individuals who have not received adequate treatment for early syphilis are at higher risk for developing late-stage complications.

Conclusion

Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with ICD-10 code A52.79 is essential for healthcare providers. Early recognition and treatment of syphilis can prevent the progression to symptomatic late stages, thereby reducing the risk of serious complications. Regular screening and education about safe sexual practices are vital components in managing and preventing syphilis infections.

Approximate Synonyms

ICD-10 code A52.79 refers to "Other symptomatic late syphilis," which encompasses various manifestations of late-stage syphilis that do not fall under more specific categories. Understanding alternative names and related terms for this code can be beneficial for healthcare professionals, coders, and researchers. Below is a detailed overview of alternative names and related terms associated with A52.79.

Alternative Names for A52.79

  1. Late Syphilis: This term broadly refers to the advanced stage of syphilis, which can manifest in various ways, including neurological and cardiovascular complications.

  2. Symptomatic Late Syphilis: This phrase emphasizes the presence of symptoms in the late stage of the disease, distinguishing it from asymptomatic cases.

  3. Tertiary Syphilis: Often used interchangeably with late syphilis, this term describes the third stage of syphilis, which can occur years after the initial infection if left untreated.

  4. Other Forms of Late Syphilis: This term can be used to describe cases that do not fit into more specific categories, such as late syphilitic oculopathy (A52.71) or cardiovascular syphilis.

  1. Syphilitic Aortitis: A condition that can occur in late syphilis, affecting the aorta and leading to serious cardiovascular complications.

  2. Neurosyphilis: A complication of syphilis that affects the nervous system, which can occur in the late stages of the disease.

  3. Gummatous Syphilis: Refers to the formation of gummas, which are soft, tumor-like growths that can occur in various tissues during late syphilis.

  4. Syphilitic Meningitis: A form of neurosyphilis where the membranes surrounding the brain become inflamed.

  5. Latent Syphilis: While not synonymous with A52.79, latent syphilis can progress to symptomatic late syphilis if not treated.

Clinical Context

Understanding these alternative names and related terms is crucial for accurate diagnosis, treatment, and coding in medical records. The manifestations of late syphilis can vary significantly, and recognizing the broader terminology can aid in identifying the condition in clinical practice.

In summary, A52.79 encompasses a range of symptoms and complications associated with late syphilis, and familiarity with its alternative names and related terms can enhance communication among healthcare providers and improve patient care.

Diagnostic Criteria

The diagnosis of ICD-10 code A52.79, which refers to "Other symptomatic late syphilis," involves specific clinical criteria and considerations. Late syphilis is characterized by the presence of symptoms that occur after the primary and secondary stages of syphilis, typically manifesting years after the initial infection. Here’s a detailed overview of the criteria used for diagnosis:

Clinical Criteria for Diagnosis

1. History of Syphilis Infection

  • A confirmed history of syphilis, particularly if the patient has previously been diagnosed with primary or secondary syphilis, is essential. This history may include serological tests that indicate past infection, such as positive results for non-treponemal tests (e.g., RPR or VDRL) and treponemal tests (e.g., FTA-ABS).

2. Symptoms of Late Syphilis

  • Patients may present with various symptoms that indicate late-stage syphilis. These can include:
    • Gummatous lesions: Soft, tumor-like growths that can occur in various tissues, including skin, bones, and organs.
    • Cardiovascular manifestations: Such as aortitis or aneurysms, which can lead to serious complications.
    • Neurological symptoms: Including neurosyphilis, which may present as meningitis, tabes dorsalis, or general paresis.

3. Serological Testing

  • Serological tests are crucial for confirming the diagnosis. In late syphilis, treponemal tests remain positive, while non-treponemal tests may show varying results. A significant increase in titers of non-treponemal tests can indicate active disease.

4. Exclusion of Other Conditions

  • It is important to rule out other conditions that may mimic the symptoms of late syphilis. This may involve additional diagnostic testing and clinical evaluation to ensure that the symptoms are indeed attributable to syphilis.

5. Clinical Examination

  • A thorough clinical examination is necessary to identify any physical signs associated with late syphilis, such as skin lesions or neurological deficits.

Conclusion

The diagnosis of A52.79 Other symptomatic late syphilis requires a comprehensive approach that includes a detailed patient history, clinical evaluation, serological testing, and the exclusion of other potential causes for the symptoms. Proper diagnosis is crucial for effective treatment and management of the disease, as late syphilis can lead to significant morbidity if left untreated. If you have further questions or need more specific information regarding treatment protocols or management strategies, feel free to ask!

Treatment Guidelines

When addressing the treatment of ICD-10 code A52.79, which refers to "Other symptomatic late syphilis," it is essential to understand the broader context of syphilis management, particularly in its late stages. Late syphilis can manifest in various forms, including cardiovascular syphilis and neurosyphilis, and requires a comprehensive treatment approach.

Overview of Late Syphilis

Late syphilis occurs when the infection has progressed beyond the primary and secondary stages, often years after initial infection. Symptoms can include gummatous lesions, cardiovascular complications, and neurological issues. The treatment primarily focuses on eradicating the Treponema pallidum bacteria, which causes syphilis, and managing any complications that arise from the disease.

Standard Treatment Approaches

1. Antibiotic Therapy

The cornerstone of treatment for late syphilis is penicillin, which is highly effective against Treponema pallidum. The recommended regimens include:

  • Benzathine Penicillin G: The standard treatment for late latent syphilis and symptomatic late syphilis is a single dose of 2.4 million units administered intramuscularly. In cases of neurosyphilis, a more intensive regimen is required.
  • Aqueous Crystalline Penicillin G: For neurosyphilis, the treatment involves administering 18-24 million units per day, given as 3-4 million units intravenously every 4 hours for 10-14 days.

2. Monitoring and Follow-Up

After initiating treatment, it is crucial to monitor the patient’s response. This typically involves:

  • Serological Testing: Follow-up serological tests should be conducted at 6, 12, and 24 months post-treatment to ensure that the titers are decreasing, indicating effective treatment.
  • Clinical Evaluation: Regular assessments to monitor for any potential complications or treatment failures.

3. Management of Complications

Patients with symptomatic late syphilis may present with complications that require additional management:

  • Cardiovascular Syphilis: Patients may need further evaluation and management for cardiovascular issues, including potential surgical interventions if significant damage has occurred.
  • Neurosyphilis: Neurological symptoms may necessitate additional treatments, including symptomatic management and possibly referral to a neurologist for specialized care.

4. Patient Education and Counseling

Educating patients about syphilis, its transmission, and the importance of completing treatment is vital. Counseling should also include:

  • Safe Sex Practices: To prevent reinfection and transmission to partners.
  • Regular Screening: Encouraging regular STI screenings for sexually active individuals, especially those at higher risk.

Conclusion

The treatment of ICD-10 code A52.79: Other symptomatic late syphilis primarily involves the administration of penicillin, with careful monitoring and management of any complications that may arise. Regular follow-up and patient education are essential components of effective treatment, ensuring that patients understand their condition and the importance of adherence to therapy. By addressing both the infection and its potential complications, healthcare providers can significantly improve patient outcomes in cases of late syphilis.

Description

ICD-10 code A52.79 refers to "Other symptomatic late syphilis," which is classified under the broader category of late syphilis (A52). This classification is part of the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), which is used for coding and classifying diagnoses in healthcare settings.

Clinical Description of Late Syphilis

Late syphilis is the final stage of syphilis infection, which is caused by the bacterium Treponema pallidum. This stage can occur years after the initial infection if left untreated. Late syphilis is characterized by a variety of systemic manifestations that can affect multiple organ systems. The symptoms may vary widely among individuals, and some may remain asymptomatic for long periods.

Symptoms and Manifestations

  1. Gummatous Syphilis: This form involves the development of gummas, which are soft, tumor-like growths that can occur in various tissues, including skin, bones, and internal organs. These lesions can be painful and may lead to significant tissue damage.

  2. Cardiovascular Syphilis: This can manifest as aortitis, which is inflammation of the aorta, potentially leading to aneurysms or other cardiovascular complications.

  3. Neurosyphilis: Although typically classified separately, late syphilis can also involve neurological symptoms, including headaches, altered mental status, and other cognitive impairments.

  4. Ocular Syphilis: This may present with visual disturbances or other eye-related symptoms, potentially leading to blindness if untreated.

Diagnosis

Diagnosis of late syphilis typically involves serological testing to detect antibodies against Treponema pallidum. Common tests include:

  • Non-treponemal tests (e.g., RPR, VDRL): These tests measure antibodies that are not specific to syphilis but indicate its presence.
  • Treponemal tests (e.g., FTA-ABS): These tests specifically detect antibodies to the bacteria and confirm the diagnosis.

Treatment

The primary treatment for late syphilis involves the administration of antibiotics, with benzathine penicillin G being the most commonly used. The treatment regimen may vary based on the severity of the symptoms and the presence of complications.

Prognosis

With appropriate treatment, the prognosis for individuals with late syphilis can be favorable, particularly if the disease has not caused significant damage to organs. However, untreated late syphilis can lead to severe complications and long-term health issues.

Conclusion

ICD-10 code A52.79 captures the complexities of other symptomatic late syphilis, highlighting the need for comprehensive clinical evaluation and management. Understanding the various manifestations and treatment options is crucial for healthcare providers to effectively address this serious condition and prevent its complications. Regular screening and early intervention remain key strategies in managing syphilis and reducing its prevalence in the population.

Related Information

Clinical Information

  • Gummatous syphilis forms soft tumor-like growths
  • Cardiovascular syphilis causes aortitis and complications
  • Neurosyphilis affects central nervous system
  • Skin lesions are painless and raised
  • Bone pain occurs due to gummatous lesions
  • Cardiovascular symptoms include chest pain and shortness of breath
  • Neurological symptoms cause cognitive decline and personality changes
  • Demographics: more prevalent in MSM and high-risk populations
  • Co-morbidities worsen syphilis manifestations
  • Untreated early syphilis increases late-stage complications risk

Approximate Synonyms

  • Late Syphilis
  • Symptomatic Late Syphilis
  • Tertiary Syphilis
  • Other Forms of Late Syphilis
  • Syphilitic Aortitis
  • Neurosyphilis
  • Gummatous Syphilis
  • Syphilitic Meningitis
  • Latent Syphilis

Diagnostic Criteria

  • Confirmed history of syphilis infection
  • Presence of gummatous lesions
  • Cardiovascular manifestations such as aortitis
  • Neurological symptoms like neurosyphilis
  • Positive treponemal tests and varying non-treponemal results
  • Significant increase in non-treponemal titers
  • Ruling out other conditions with similar symptoms

Treatment Guidelines

  • Penicillin is primary antibiotic treatment
  • Benzathine Penicillin G for symptomatic late syphilis
  • Aqueous Crystalline Penicillin G for neurosyphilis
  • Serological Testing at 6, 12 and 24 months post-treatment
  • Clinical Evaluation every 3-6 months
  • Cardiovascular Syphilis requires additional management
  • Neurological symptoms require specialized care

Description

Coding Guidelines

Excludes 1

  • syphilitic leukoderma (secondary) (A51.39)

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.